Innovative Treatments Transform Vocal Cord Recovery

David Metherell, a 45-year-old critical care nurse, has experienced a significant transformation in his ability to communicate after undergoing a novel treatment for his damaged vocal cords. Metherell, who contracted a rare strain of human papillomavirus (HPV) at nine months old, faced severe vocal limitations throughout his life, including an inability to sing or shout. Following 21 surgeries by age six, his vocal cords remained scarred, resulting in a permanent croaky voice. However, a new procedure involving platelet-rich plasma (PRP) injections has provided him with newfound vocal capabilities, allowing him to read bedtime stories to his son.

The Independent

The treatment, conducted at the ear, nose, and throat (ENT) clinic at Guy's Hospital, utilizes PRP derived from the patient's own blood to rejuvenate vocal cords. This method, previously employed in NHS clinics for knee and tendon injuries, has shown promising results in vocal recovery. Metherell's consultant, Shiying Hey, reported that all 10 patients treated with this approach have experienced improvements in their voices. After three injections, Metherell noted a significant enhancement in his ability to communicate in various social and work settings.

The Independent

Research supports the efficacy of PRP injections for vocal cord recovery. A study published in the Journal of Voice in 2025 involved 109 injections administered to 48 participants with vocal cord damage between 2021 and 2023. Results indicated that over 70% of participants reported moderate to significant vocal improvement one month after their final injection, with more than two-thirds showing observable enhancements in their vocal cords.

The Independent

In addition to PRP treatments, innovative technologies are being developed to assist individuals with speech difficulties. The University of Cambridge has introduced Revoice, a device designed to facilitate natural communication without invasive procedures. This technology employs sensors and artificial intelligence to interpret speech signals and emotional cues, converting them into spoken words. In a small trial involving five patients with dysarthria, Revoice demonstrated high accuracy, with only 4.2% of words and 2.9% of sentences being incorrectly interpreted.

The Independent

While these advancements in vocal cord treatment and speech technology are promising, some experts express caution regarding the long-term effectiveness and accessibility of such treatments. The reliance on innovative technologies may not be feasible for all patients, particularly those with limited access to healthcare resources.

The Independent

“I've never been able to sing, I've never been able to shout - I've just been limited in so many ways,” — David Metherell, Patient

The Independent

“She explained that it is cheaper than other treatments as they can use the patient’s own blood.” — Shiying Hey, Consultant

The Independent

“The University of Cambridge created Revoice, a technology which could cut out the need for invasive brain implants and enables patients to communicate naturally.” — University of Cambridge Research Team

The Independent

As these treatments and technologies continue to evolve, they hold the potential to significantly improve the quality of life for individuals with vocal impairments.

The Independent